The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study
Abstract
Clinical and epidemiologic evidence suggest serious cutaneous reactions to antiepileptic drugs are more likely to occur during the first few months of use. However, studies have quantified risk for these reactions by including all users and their entire duration of use in denominator estimates possibly underestimating the risk. The objective of this study was to measure risk of serious cutaneous reactions in new users of phenytoin, carbamazepine, or valproic acid. We identified serious cutaneous reactions that included hospitalization and occurred within 60 days of the first or second prescription for new users of each study drug in the Saskatchewan Health data files. To classify outcome diagnoses, a dermatologist reviewed hospital discharge summaries. In 8,888 new phenytoin users there were eight serious cutaneous reactions. These included two probable and two possible cases of hypersensitivity syndrome, yielding a risk of 2.3 to 4.5 per 10,000 for this syndrome. There were six serious cutaneous reactions in 9,738 new carbamazepine users. These included one probable case and four possible cases of hypersensitivity syndrome, yielding a risk of 1 to 4.1 per 10,000 for this syndrome. There were no confirmed serious cutaneous diagnoses in 1,504 new valproate users. During the first few weeks of initiating therapy with phenytoin or carbamazepine, the clinician should be aware of the uncommon but not rare possibility that a cutaneous eruption could evolve into a significantly more serious reaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Suarez, F. L., Savaiano, D. A., & Levitt, M. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507063330101 · Cited by 507
Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome: An Epidemiologic Study From West Germany
Schöpf, E. (1991) · Archives of Dermatology · doi:10.1001/archderm.1991.01680050083008 · Cited by 399
Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985
Roujeau, J. (1990) · Archives of Dermatology · doi:10.1001/archderm.126.1.37 · Cited by 391
Chan, H.-L. (1990) · Archives of Dermatology · doi:10.1001/archderm.1990.01670250049006 · Cited by 371
Duchenne muscular dystrophy: High frequency of deletions
Bartlett, R. J., Pericak-Vance, M. A., Koh, J., Yamaoka, L. H., Chen, J. C., Hung, W. Y., Speer, M. C., Wapenaar, M. C., B. Van Ommen, G. J., Bakker, E., et al. (1988) · Neurology · doi:10.1212/wnl.38.1.1 · Cited by 196
Hypercalcemia of malignancy revisited.
Mundy, G. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113555 · Cited by 190
A Population-Based Study of the Risk of Recurrence of Birth Defects
Lie, R. T., Wilcox, A. J., & Skjaerven, R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407073310101 · Cited by 164
Familial occurrence of hypersensitivity to phenytoin
Gennis, M. A., Vemuri, R., Burns, E. A., Hill, J. V., Miller, M. A., & Spielberg, S. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90216-k · Cited by 151
Jun and Fos regulation of NAD(P)H
Jaiswal, A. K. (1994) · Pharmacogenetics · doi:10.1097/00008571-199402000-00001 · Cited by 48
Taurine in normal and diseased human skeletal muscle
Airaksinen, E. M., Paljärvi, L., Partanen, J. V., Collan, Y. U., Laakso, R., & Pentikäinen, T. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1990.tb00923.x · Cited by 29
Cited by
Comorbidities of epilepsy: current concepts and future perspectives
Keezer, M. R., Sisodiya, S. M., & Sander, J. W. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00225-2 · Cited by 778
Man, C. B. L., Kwan, P., Baum, L., Yu, E., Lau, K. M., Cheng, A. S. H., & Ng, M. H. L. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01022.x · Cited by 507
Rzany, B., Correia, O., Kelly, J. P., Naldi, L., Auquier, A., & Stern, R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05418-x · Cited by 348
Self-citationLamotrigine‐Associated Rash: Risk/Benefit Considerations in Adults and Children
Guberman, A. H., Besag, F. M. C., Brodie, M. J., Dooley, J. M., Duchowny, M. S., Pellock, J. M., Richens, A., Stern, R. S., & Trevathan, E. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00807.x · Cited by 339
Self-citationPhillips, E. J., Sukasem, C., Whirl‐Carrillo, M., Müller, D. J., Dunnenberger, H. M., Chantratita, W., Goldspiel, B., Chen, Y., Carleton, B. C., George, A. L., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1004 · Cited by 328
Metadata
- Authors
- Tennis, P., & Stern, R. S.
- Venue
- Neurology
- Published
- 1997-08
- Volume
- 49
- Issue
- 2
- Pages
- 542-546
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2061751608
- Cited by
- 261
- References
- 10
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study. https://app.cochat.ai/papers/10.1212/wnl.49.2.542
- The paper
- Tennis, P., & Stern, R. S. (1997). Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study. Neurology. https://doi.org/10.1212/wnl.49.2.542
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
